Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Lloydspharmacy parent company changes name to reflect US owners

Lloydspharmacy’s parent company has changed its name to reflect its American owners.

As of today (November 26), Celesio UK will be called McKesson UK, it announced.

Despite US wholesaling and healthcare technology giant McKesson having taken over Celesio in 2014, the latter company has continued to operate under its existing name until now.

McKesson UK CEO Toby Anderson, who joined the business as Celesio UK CEO in May, said: “We have been part of the McKesson family for over four years now.

“In the UK, we have to be prepared to meet the evolving needs of patients and care delivery – and now seemed an appropriate time to move to our new brand.

“The McKesson name is one that resonates particularly with pharmaceutical manufacturers and other strategic partners that we work with,” he added

The Lloydspharmacy and AAH Pharmaceuticals brand names will not change, McKesson UK stressed.

What do you make of the name change?

Related Content

Topics

         
Pharmacist
New Zealand
£ Competitive

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel